Skip to content
Est. 1998 proudly celebrating 27 years of standing behind American companies
US-Listed Public Company Profile built from SEC and market records · June 2026

Viatris Inc (VTRS)

$18.29 +1.61% NASDAQ: VTRS · 15-min delayed
  • CANONSBURG, Pennsylvania
  • Public · NASDAQ: VTRS
  • 30,000 employees
  • Founded 2020
$20.1BMarket cap
$14.3BRevenue · FY2025
$0Net income
30,000Employees
VTRSNASDAQ
1973IPO

About Viatris Inc

Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. The remaining 60% of sales are derived from its portfolio of legacy products, which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.

This profile is unclaimed. An authorized representative can claim it free to control the page and activate the embeddable Verified badge.

Reported figures

Financial summary

Revenue FY2025
$14.3B
Net income
$0
Total assets
$37.2B
Market cap
$20.1B

Source: SEC EDGAR · updated Jun 7, 2026

NASDAQ: VTRS
$18.29 +1.61%

15-minute delayed · data by Polygon.io

Past year · hover for prices

$9.49 $18.66

52-week range

Market cap
$20.1B
Dividend yield
2.62%
Shares outstanding
1.1B
Open
—
Day range
–
Prev close
—
Volume
—
IPO date
Feb 23, 1973

Viatris Inc (VTRS) Stock Price

  • Trading near its 52-week high.
  • Pays a dividend yielding about 2.62% annually.

Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.

Peers & competitors

No reviews yet. Be the first to review Viatris Inc.

Write a review
Newsroom

News about Viatris Inc

News & sentiment via Polygon.io

FAQ

Viatris Inc: frequently asked questions

Is Viatris Inc an American company?

Yes — Viatris Inc is an American company. Viatris Inc is incorporated in Delaware, United States and headquartered in Canonsburg, Pennsylvania. Its legal-entity record reports no foreign parent — the company is independently American-owned.

Where is Viatris Inc incorporated?

Viatris Inc is legally incorporated in Delaware, United States, according to its GLEIF legal-entity record.

Who owns Viatris Inc?

Viatris Inc reports no parent company in its legal-entity record — it is independently owned rather than a subsidiary.

Is Viatris Inc traded on a US stock exchange?

Yes — Viatris Inc trades under the ticker VTRS on the NASDAQ.

Where is Viatris Inc headquartered?

Viatris Inc is headquartered in Canonsburg, Pennsylvania, United States.

Is Viatris Inc publicly traded?

Yes — Viatris Inc is a publicly traded company. Its stock trades under the ticker symbol VTRS on the NASDAQ.

What does Viatris Inc do?

Viatris Inc is an American Pharmaceuticals company in the Health & Beauty sector.

When was Viatris Inc founded?

Viatris Inc was founded in 2020.

Explore

Similar companies

Browse all →